![Transparency Market Researchが調査・発行した産業分析レポートです。旅行者下痢治療の世界市場：薬物クラス別（経口補水療法（ORS）、下痢止め剤、抗生物質[アジスロマイシン、シプロフロキサシン、キノロン、リファキシミ]、ワクチン/予防薬、その他）、病原菌別（細菌[E.コリ、サルモネラSpp、その他]、ウイルス、原虫）、年齢別（大人、子供）、流通経路別（小売薬局、病院薬局、オンライン薬局） / Traveler’s Diarrhea Treatment Market (Drug Class: Oral Rehydration Therapy (ORS), Antidiarrheal Agents, Antibiotics [Azithromycin, Ciprofloxacin, Quinolones, and Rifaximi], Vaccines/Prophylactics, and Others; Pathogen: Bacteria [E. Coli, Salmonella Spp, and Others], Viruses, and Protozoa; Age Group: Adults and Children; and Distribution Channel: Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / D0JU09142資料のイメージです。](https://www.marketresearch.co.jp/images-folder2/report-contents-72.gif) | • レポートコード：D0JU09142 • 出版社/出版日：Transparency Market Research / 2019年12月23日 • レポート形態：英文、PDF、240ページ • 納品方法：Eメール • 産業分類：製薬 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、旅行者下痢治療の世界市場について調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、市場概要、薬物クラス別（経口補水療法（ORS）、下痢止め剤、抗生物質[アジスロマイシン、シプロフロキサシン、キノロン、リファキシミ]、ワクチン/予防薬、その他）分析、病原菌別（細菌[E.コリ、サルモネラSpp、その他]、ウイルス、原虫）分析、年齢別（大人、子供）分析、流通経路別（小売薬局、病院薬局、オンライン薬局）分析、地域別分析、競争状況などの構成でお届けいたします。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場動向 ・市場概要 ・旅行者下痢治療の世界市場：薬物クラス別（経口補水療法（ORS）、下痢止め剤、抗生物質[アジスロマイシン、シプロフロキサシン、キノロン、リファキシミ]、ワクチン/予防薬、その他） ・旅行者下痢治療の世界市場：病原菌別（細菌[E.コリ、サルモネラSpp、その他]、ウイルス、原虫） ・旅行者下痢治療の世界市場：年齢別（大人、子供） ・旅行者下痢治療の世界市場：流通経路別（小売薬局、病院薬局、オンライン薬局） ・旅行者下痢治療の世界市場：地域別 ・競争状況 |
Traveler’s Diarrhea Treatment Market – Scope of the Report
TMR’s report on the traveler’s diarrhea treatment market studies past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the market during the forecast period from 2019 to 2027. The report provides the overall revenue of the traveler’s diarrhea treatment market for the period from 2017-2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the traveler’s diarrhea treatment market during the forecast period.
The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global traveler’s diarrhea treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global traveler’s diarrhea treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on changing competitive dynamics in the global traveler’s diarrhea treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global traveler’s diarrhea treatment market.
The report delves into the competitive landscape of the global traveler’s diarrhea treatment market. Key players operating in the global traveler’s diarrhea treatment market are identified, and each one of them is profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOTs are some of the attributes of players in the global traveler’s diarrhea treatment market that have been profiled in this report.
Key Questions Answered in the Traveler’s Diarrhea Treatment Market Report
What is the scope of growth of product companies in the traveler’s diarrhea treatment market?
What will be the Y-o-Y growth of the traveler’s diarrhea treatment market between 2019 and 2027?
What is the influence of changing trends in technologies on the global traveler’s diarrhea treatment market?
Will North America continue to be the most profitable regional market for traveler’s diarrhea treatment product providers?
Which factors will impede the growth of the traveler’s diarrhea treatment market during the forecast period?
Which are the leading companies in the global traveler’s diarrhea treatment market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global traveler’s diarrhea treatment market, and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary sources referred to by analysts during the production of the global traveler’s diarrhea treatment market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the traveler’s diarrhea treatment market as primary sources.
These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from traveler’s diarrhea treatment market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global traveler’s diarrhea treatment market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global traveler’s diarrhea treatment market more reliably and accurately.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Traveler’s Diarrhea Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Drug Class Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Surge in Number of Travelers
4.3.1.2. Awareness Among Travelers
4.3.1.3. Evolution of Pathogens and Antimicrobial Resistance
4.3.1.4. Rise in Number of Food Contamination Cases
4.3.1.5. New Therapeutics in Development
4.3.2. Restraints
4.3.2.1. Trend of Self-medication Using OTC Products and Misuse of Antibiotics
4.3.2.2. Awareness about Hygiene
4.3.2.3. Introduction of Generic Products
4.3.3. Opportunities
4.4. Global Traveler’s Diarrhea Treatment Market Analysis and Forecasts, 2017–2027
5. Market Outlook
5.1. Overview of Guidelines for Diagnosis & Treatment of Traveler’s Diarrhea
5.2. Private/Public Sector Drug Supply Chain by Region/Country
5.3. Pipeline Analysis
5.4. Epidemiology of Traveler’s Diarrhea by Region/Sub-region
5.5. Overview of Causes/Percentage of Bacteria, Viruses and Protozoa Causing Traveler’s Diarrhea
6. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Drug Class
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class, 2017–2027
6.3.1. Oral Rehydration Therapy (ORS)
6.3.2. Antidiarrheal Agents
6.3.2.1. Antibiotics
6.3.2.2. Azithromycin
6.3.2.3. Ciprofloxacin
6.3.2.4. Quinolones
6.3.2.5. Rifaximin
6.3.3. Vaccines/prophylactics
6.3.4. Others
6.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Drug Class
7. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Pathogen
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
7.3.1. Bacteria
7.3.1.1. E. Coli
7.3.1.2. Salmonella Spp
7.3.1.3. Others
7.3.2. Viruses
7.3.3. Protozoa
7.3.3.1. Giardiasis
7.3.3.2. Cryptosporidium parvum
7.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Pathogen
8. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Age
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
8.3.1. Adults
8.3.2. Children
8.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Age
9. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Distribution Channel
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
9.3.1. Retail Pharmacies
9.3.2. Hospital Pharmacies
9.3.3. Online Pharmacies
9.4. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Distribution Channel
10. Global Traveler’s Diarrhea Treatment Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Traveler’s Diarrhea Treatment Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Traveler’s Diarrhea Treatment Market Attractiveness, by Region
11. North America Traveler’s Diarrhea Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027
11.2.1. Oral Rehydration Therapy (ORS)
11.2.2. Antidiarrheal Agents
11.2.3. Antibiotics
11.2.3.1. Azithromycin
11.2.3.2. Ciprofloxacin
11.2.3.3. Quinolones
11.2.3.4. Rifaximin
11.2.4. Vaccines/prophylactics
11.2.5. Others
11.3. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
11.3.1. Bacteria
11.3.1.1. E. Coli
11.3.1.2. Salmonella Spp
11.3.1.3. Others
11.3.2. Viruses
11.3.3. Protozoa
11.3.3.1. Giardiasis
11.3.3.2. Cryptosporidium parvum
11.4. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
11.4.1. Adults
11.4.2. Children
11.5. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
11.5.1. Retail Pharmacies
11.5.2. Hospital Pharmacies
11.5.3. Online Pharmacies
11.6. North America Traveler’s Diarrhea Treatment Market Value Forecast, by Country, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Traveler’s Diarrhea Treatment Market Attractiveness Analysis
11.7.1. By Drug Class
11.7.2. By Pathogen
11.7.3. By Age
11.7.4. By Distribution Channel
11.7.5. By Country
12. Europe Traveler’s Diarrhea Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027
12.2.1. Oral Rehydration Therapy (ORS)
12.2.2. Antidiarrheal Agents
12.2.3. Antibiotics
12.2.3.1. Azithromycin
12.2.3.2. Ciprofloxacin
12.2.3.3. Quinolones
12.2.3.4. Rifaximin
12.2.4. Vaccines/prophylactics
12.2.5. Others
12.3. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
12.3.1. Bacteria
12.3.1.1. E. Coli
12.3.1.2. Salmonella Spp
12.3.1.3. Others
12.3.2. Viruses
12.3.3. Protozoa
12.3.3.1. Giardiasis
12.3.3.2. Cryptosporidium parvum
12.4. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
12.4.1. Adults
12.4.2. Children
12.5. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
12.5.1. Retail Pharmacies
12.5.2. Hospital Pharmacies
12.5.3. Online Pharmacies
12.6. Europe Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Traveler’s Diarrhea Treatment Market Attractiveness Analysis
12.7.1. By Drug Class
12.7.2. By Pathogen
12.7.3. By Age
12.7.4. By Distribution Channel
12.7.5. By Country/Sub-region
13. Asia Pacific Traveler’s Diarrhea Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class, 2017–2027
13.2.1. Oral Rehydration Therapy (ORS)
13.2.2. Antidiarrheal Agents
13.2.3. Antibiotics
13.2.3.1. Azithromycin
13.2.3.2. Ciprofloxacin
13.2.3.3. Quinolones
13.2.3.4. Rifaximin
13.2.4. Vaccines/prophylactics
13.2.5. Others
13.3. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
13.3.1. Bacteria
13.3.1.1. E. Coli
13.3.1.2. Salmonella Spp
13.3.1.3. Others
13.3.2. Viruses
13.3.3. Protozoa
13.3.3.1. Giardiasis
13.3.3.2. Cryptosporidium parvum
13.4. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
13.4.1. Adults
13.4.2. Children
13.5. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
13.5.1. Retail Pharmacies
13.5.2. Hospital Pharmacies
13.5.3. Online Pharmacies
13.6. Asia Pacific Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Traveler’s Diarrhea Treatment Market Attractiveness Analysis
13.7.1. By Drug Class
13.7.2. By Pathogen
13.7.3. By Age
13.7.4. By Distribution Channel
13.7.5. By Country/Sub-region
14. Latin America Traveler’s Diarrhea Treatment Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Traveler’s Diarrhea Market Value Forecast, by Drug Class , 2017–2027
14.2.1. Oral Rehydration Therapy (ORS)
14.2.2. Antidiarrheal Agents
14.2.3. Antibiotics
14.2.3.1. Azithromycin
14.2.3.2. Ciprofloxacin
14.2.3.3. Quinolones
14.2.3.4. Rifaximin
14.2.4. Vaccines/prophylactics
14.2.5. Others
14.3. Latin America Traveler’s Diarrhea Market Value Forecast, by Pathogen, 2017–2027
14.3.1. Bacteria
14.3.1.1. E. Coli
14.3.1.2. Salmonella Spp
14.3.1.3. Others
14.3.2. Viruses
14.3.3. Protozoa
14.3.3.1. Giardiasis
14.3.3.2. Cryptosporidium parvum
14.4. Latin America Traveler’s Diarrhea Market Value Forecast, by Age, 2017–2027
14.4.1. Adults
14.4.2. Children
14.5. Latin America Traveler’s Diarrhea Market Value Forecast, by Distribution Channel, 2017–2027
14.5.1. Retail Pharmacies
14.5.2. Hospital Pharmacies
14.5.3. Online Pharmacies
14.6. Latin America Traveler’s Diarrhea Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Traveler’s Diarrhea Market Attractiveness Analysis
14.7.1. By Drug Class
14.7.2. By Pathogen
14.7.3. By Age
14.7.4. By Distribution Channel
14.7.5. By Country/Sub-region
15. Middle East & Africa Traveler’s Diarrhea Treatment Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Drug Class , 2017–2027
15.2.1. Oral Rehydration Therapy (ORS)
15.2.2. Antidiarrheal Agents
15.2.3. Antibiotics
15.2.3.1. Azithromycin
15.2.3.2. Ciprofloxacin
15.2.3.3. Quinolones
15.2.3.4. Rifaximin
15.2.4. Vaccines/prophylactics
15.2.5. Others
15.3. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Pathogen, 2017–2027
15.3.1. Bacteria
15.3.1.1. E. Coli
15.3.1.2. Salmonella Spp
15.3.1.3. Others
15.3.2. Viruses
15.3.3. Protozoa
15.3.3.1. Giardiasis
15.3.3.2. Cryptosporidium parvum
15.4. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Age, 2017–2027
15.4.1. Adults
15.4.2. Children
15.5. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Distribution Channel, 2017–2027
15.5.1. Retail Pharmacies
15.5.2. Hospital Pharmacies
15.5.3. Online Pharmacies
15.6. Middle East & Africa Traveler’s Diarrhea Treatment Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Traveler’s Diarrhea Treatment Market Attractiveness Analysis
15.7.1. By Drug Class
15.7.2. By Pathogen
15.7.3. By Age
15.7.4. By Distribution Channel
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share Analysis/Ranking By Company (2018)
16.3. Company Profiles
16.3.1. Johnson & Johnson (Johnson & Johnson Consumer Inc.)
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Bausch Health Companies Inc. (Salix Pharmaceuticals)
16.3.2.1. Company Overview
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. COSMO PHARMACEUTICALS
16.3.3.1. Company Overview
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Immuron
16.3.4.1. Company Overview
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Valneva SE
16.3.5.1. Company Overview
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Sun Pharmaceutical Industries Ltd.
16.3.6.1. Company Overview
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Norgine
16.3.7.1. Company Overview
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Perrigo Company plc
16.3.8.1. Company Overview
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. Bayer AG
16.3.9.1. Company Overview
16.3.9.2. Company Financials
16.3.9.3. SWOT Analysis
List of TablesTable 01: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 03: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 04: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 05: Global Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 07: North America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 08: North America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 09: North America Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 10: North America Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 11: Europe Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 12: Europe Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 13: Europe Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 14: Europe Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 15: Europe Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 16: Asia Pacific Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Asia Pacific Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 18: Asia Pacific Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 19: Asia Pacific Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 20: Asia Pacific Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 21: Latin America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Latin America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 23: Latin America Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 24: Latin America Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 25: Latin America Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 26: Middle East & Africa Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 27: Middle East & Africa Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Product Type, 2017–2027
Table 28: Middle East & Africa Clinical Chemistry Analyzers Market Value (US$ Mn) Forecast, by Technology, 2017–2027
Table 29: Middle East & Africa Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by Modality, 2017–2027
Table 30: Middle East & Africa Clinical Chemistry Analyzers market Value (US$ Mn) Forecast, by End User, 2017–2027